Ambassadors to the World

KRF Ambassadors play a crucial role in expanding our network of scientists and clinicians globally. KRF realizes that making progress in this disorder is dependent on global collaboration among all who either treat keloid patients, or do research in it.

Ambassador to the Arabic Speaking Countries

Haythem Ali, MD

Dr. Haythem Ali is an active member of Keloid Research Foundation and our Ambassador to the Arabic Speaking Countries. Dr. Ali is a medical oncologist at Henry Ford Hospital in Detroit Michigan and a clinical assistant professor medicine at the Wayne State University School of Medicine. Dr. Ali's Clinical and academic interests are in discovering the impact of ethnic disparities in the biology of different neoplastic processes as well as keloid disorder. Dr. Ali became interested in keloid disorder as it is another disorder where ethnicity plays a significant role in the biology and clinical presentation of the disease process.


Ambassador to South Africa

Jonel May Breytenbach, MD

Dr. Jonel May Breytenbach is an active member of Keloid Research Foundation and our Ambassador to South Africa. Dr. Breytenbach is in her final year of Plastic Surgery Residency at Sefako Makgatho Health Sciences in Gauteng in South Africa. The Sefako Makgatho Health Sciences Plastic Surgery Department sees a great number of patients with advanced keloids, which are mostly triggered due to trauma and burns. She has special interest in multi-modality treatment of patients with advanced keloid disorder.


Ambassador to United States

Reza Ghohestani, MD, PhD

Dr. Reza Ghohestani is an active member of the board of directors of KRF and our Ambassador to United States. Dr. Ghohestani is an academic dermatologist, and a basic science researcher, based in in San Antonio, Texas. For years, Dr. Ghohestani has lent his support to KRF. He was the force behind our Spring 2017 Symposium in Marrakesh and also the visionary for establishing the Journal of Keloid Research. KRF is happy to have Dr. Ghohestani as a member of its Board of Directors.


Ambassador to France

Gwenael Rolin, PhD

Dr. Gwenael Rolin is the Editor in Chief of the Journal of Keloid Research and our Ambassador to France. Dr. Rolin is also the lecturer at the Faculty of Medicine (Bourgogne Franche-Comte University) and at the Biomedical Engineer school of Besancon (ISIFC - International Master Degree) where he teaches courses in Cellular and Tissue Engineering, Regenerative Medicine, Biotechnology and Advanced Therapy Medicinal Product.


Ambassador to New Zealand

Swee T Tan, ONZM, MBBS, FRACS,PhD

Based in Wellington, New Zealand, Dr. Swee Tan is the Founder and Executive Director, Gillies McIndoe Research Institute and a Consultant Plastic & Cranio-Maxillofacial Surgeon at Hutt Hospital, and our ambassador to New Zealand. An elected member of 13 national and international professional and scientific societies, Dr Tan is a recipient of 19 science prizes and 26 honours and awards including the KEA World Class New Zealand Award, the Officer of New Zealand Order of Merit from the Queen, and the Fervent Global Love of Lives Medal. A holder of six patents, he is an author of over 150 publications in peer-reviewed journals, books and book chapters and has delivered over 350 lectures at conferences. Dr Tan is a Member of the Editorial Advisory Board of the Journal of Plastic, Reconstructive & Aesthetic Surgery, an Associate Editor of Frontiers in Surgery, Plastic and Reconstructive Surgery, and Plastic and Reconstructive Surgery Global Open, and a reviewer of 32 other medical and science journals.


Ambassador to Saudi Arabia

Mansour A. Alghamdi, PhD

Dr. Alghamdi is an active member of KRF and our Ambassador to Saudi Arabia. Dr. Alghamdi is an assistant professor at the Department of Human Anatomy, College of Medicine, King Khalid University, Saudi Arabia. He received his PhD degree in 2016 from the University of Western Australia investigating the role of epigenetic modification in keloid scar pathology. His research interests focus on understanding the molecular basis for keloid scarring, the development of targeted therapies, burn injury prevention and education.


Ambassador to Switzerland

Juerg Hafner, MD

Prof. Juerg Hafner is an active member of KRF and our ambassador to Switzerland. Prof. Hafner is an internationally known dermatological surgeon at the University Hospital of Zurich in the Department of Dermatology. He was the founder Vice President of the Swiss Association of Wound Treatment and recipient of multiple awards from the Swiss Society of Phlebology, Swiss Society of Angiology and Austrian Society of Phlebology and Dermatological Surgery. Since 2011, Prof. Hafner has been the President of the Swiss Society of Dermatology and Venereology. Prof. Hafner has the special interest in keloid research and management of keloid patients. He is also a member of the editorial board of the Journal of Keloid Research.


Ambassador to South Korea

Tae Hwan Park, MD, PhD

Dr. Tae Hwan Park is an active member of KRF, our scientific board member as well as our Ambassador to South Korea. Dr. Park is a board certified plastic surgeon in the Department of Plastic and Reconstructive Surgery and assistant professor at CHA Bundang Medical center in South Korea. He is author of numerous keloid publications. Dr. Park has extensive experience in treating patients with keloid disorder. KRF is happy to have Dr. Park as a member of its Scientific Board.


Ambassador to Serbia

Tamara Maravic-Gidakovic, MD

Dr. Tamara Maravic-Gidakovi is our Ambassador to Serbia. Dr. Maravic specializes in Dermatology and Venerology. Her medical practice (Dermanova)is located in Belgrade. She has special interest in science of keloid disorder and has been supportive of KRF initiatives.

LATEST NEWS

    3rd International Keloid Symposium:

    (July 15, 2018) KRF is proud to announce that the 2nd was successfully held on June 7-8, 2018 in Rome, Italy with attendees from 22 different countries. During this meeting, KRF was invited to host the 3rd International Keloid Symposium in Beijing. Since the Rome meeting, the organizing committee has worked hard to make this a reality. We are now pleased to announce that our next meeting, the 3rd International Keloid Symposium, which will be a three day meeting will be held in Beijing, China on April 19-21 at the Lecture Hall of the Peking Union Medical College Hospital. Click on the image below to be directed to the symposium website.

    2nd International Keloid Symposium:

    (January 18, 2018) KRF is proudly announcing that the 2nd will be held on June 7-8, 2018 in Rome, Italy. Click on the image below to be directed to the symposium website.

    Notice of 501 (C)(3) Status:

    (February 1, 2017) Keloid Research Foundation has been determined by the US Internal Revenue Service (IRS) to be exempt from federal income tax under Internal Revenue Code (IRC) Section 501(C)(3). Donors can deduct contributions they make to KRF under IRC Section 170. Click here to view the 501(C)(3) Exemption Document.

    Journal of Keloid Research:

    (December 3, 2016)KRF is proud to announce establishment of Keloid Research, an open access scientific publication of the Keloid Research Foundation. Until now, keloid manuscripts have been published in a variety of journals. Our goal is to create a centralized publishing platform for all researchers who are passionate about this disorder, so that relevant clinical and laboratory research can be published in one place and under one umbrella. The journal is aiming to provide an international forum for the publication of original work, describing basic science, translational and clinical investigations in keloid disorder.

    Keloid Staging System:

    (August 19, 2016) In his most recent publication, "Neck Keloids: evaluation of risk factors and recommendation for keloid staging system" Dr. Tirgan has designed a staging system that allows for proper categorization and grouping of keloid patients into various stages.

    To assess each keloid patient properly, to better understand the natural history of this disorder, and to be able to compare future keloid study results among various patients groups, we clearly need a staging system that can allow us to describe the severity keloid disorder based on the size, location and/or extent of the keloidal lesions; as well as history of surgery or radiation therapy, and perhaps other factors that are currently unknown to us. Please click HERE to read more.